Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3

Chemico-Biological Interactions

Volumn 213, Issue 1, 2014, Pages 60-68

  Yang, Mon Yuan ^a   Wang, Chau Jong ^a,b   Chen, Nai Fang ^a   Ho, Wen Hsin ^a   Lu, Fung Jou ^a   Tseng, Tsui Hwa ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Fas; Luteolin; Paclitaxel; STAT3

Indexed keywords

CASPASE 3; CASPASE 8; FAS ANTIGEN; LUTEOLIN; PACLITAXEL; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER MODEL; CANCER SIZE; CANCER TRANSPLANTATION; CELL STRAIN; CELL STRAIN MDA MB 231; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MONOTHERAPY; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

APOPTOSIS; FAS; LUTEOLIN; PACLITAXEL; STAT3;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; LUTEOLIN; MICE; MICE, NUDE; PACLITAXEL; STAT3 TRANSCRIPTION FACTOR;

EID: 84895174074     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.02.002     Document Type: Article

References (24)

1. S.B. Horwitz Mechanism of action of Taxol Trends Pharmacol. Sci. 13 1992 134 136
2. J. George, N.L. Banik, and S.K. Ray Molecular mechanisms of taxol for induction of cell death in glioblastomas S.K. Ray, Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies 2010 Springer New York 283 298
3. H. Maier-Lenz, B. Hauns, and B. Haering et al. Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics Semin. Oncol. 24 Suppl. 19 1997 16 19
4. J.P. MacKeigan, D.J. Taxman, D. Hunter, H.S. Earp III, L.M. Graves, and J.P.Y. Ting Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen activated protein kinase kinase inhibition Clin. Cancer Res. 8 2002 2091 2099
5. H.J. Kang, S.H. Lee, J.E. Price, and L.S. Kim Curcumin suppresses the paclitaxel-induced nuclear factor-κB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model Breast J. 15 2009 223 229
6. H.C. Kuo, H.J. Lee, C.C. Hu, H.I. Shun, and T.H. Tseng Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells Toxicol. Appl. Pharmacol. 210 2006 55 62
7. S.W. Fesik Promoting apoptosis as a strategy for cancer drug discovery Nat. Rev. Cancer 5 2005 876 885
8. S.H. Kaufmann, and W.C. Earnshaw Induction of apoptosis by cancer chemotherapy Exp. Cell Res. 256 2000 42 49
9. N. Jing, and D.J. Tweardy Targeting Stat3 in cancer therapy Anticancer Drugs 16 2005 601 607
10. J. Avruch MAP kinase pathways: the first twenty years Biochim. Biophys. Acta 1773 2007 1150 1160
11. Y. Lin, R. Shi, X. Wang, and H.M. Shen Luteolin, a flavonoid with potentials for cancer prevention and therapy Curr. Cancer Drug Targets 8 2008 634 646
12. H.J. Lee, C.J. Wang, H.C. Kuo, F.P. Chou, L.F. Jean, and T.H. Tseng Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK Toxicol. Appl. Pharmacol. 203 2005 124 131
13. W.J. Lee, W.K. Chen, C.J. Wang, W.L. Lin, and T.H. Tseng Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells Toxicol. Appl. Pharmacol. 226 2008 178 191
14. W.L. Lin, Y.J. Lee, S.M. Wang, P.Y. Huang, and T.H. Tseng Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase- 2 activity in MDA-MB-231 breast cancer cells by camphoratimide B Eur. J. Pharmacol. 680 2012 8 15
15. D.A. Vorobiof, B.L. Rapoport, M.R. Chasen, C. Slabber, G. McMichael, R. Eek, and C. Mohammed First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: a multicentre phase II study Breast 13 2004 219 226
16. C.D. Scripture, W.D. Figg, and A. Sparreboom Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives Curr. Neuropharmacol. 4 2006 165 172
17. J. George, N.L. Banik, and S.K. Ray Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells Neurochem. Res. 34 2009 66 78
18. J.A. Ross, and C.M. Kasum Dietary flavonoids: bioavailability, metabolic effects, and safety Annu. Rev. Nutr. 22 2002 19 34
19. A.Y. Choi, J.H. Choi, H. Yoon, K.Y. Hwang, M.H. Noh, W. Choe, K.S. Yoon, J. Ha, E.J. Yeo, and I. Kang Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells Eur. J. Pharmacol. 668 2011 115 126
20. M.J. Kim, J.S. Woo, C.H. Kwon, J.H. Kim, Y.K. Kim, and K.H. Kim Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines Cell Biol. Int. 36 2012 339 344
21. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia J. Am. Chem. Soc. 93 1971 2325 2327
22. F. Impens, P.V. Damme, H. Demol, J.V. Damme, J. Vandekerckhove, and K. Gevaert Mechanistic insight into taxol-induced cell death Oncogene 27 2008 4580 4591
23. J.M. Dziadyk, M. Sui, X. Zhu, and W. Fan Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest Anticancer Res. 24 2004 27 36
24. V. Vivat-Hannah, D. You, C. Rizzo, J.P. Daris, P. Lapointe, F.C. Zusi, A. Marinier, M.V. Lorenzi, and M.M. Gottardis Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel) Cancer Res. 61 2001 8703 8711